from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3183/-

LFCtreatmentdescriptionclass of inhibitor

1.609

Amikacinug/mL Amikacintranslation

1.403

Cap5-10ug/mL Capreomycintranslation

0.714

Rox10-50 ug/mL Roxithromycintranslation

0.357

SM2-5 ug/mL Streptomycintranslation

1.822

Tet5-10 ug/mL Tetracyclinetranslation

-0.201

Rif0.2-5ug/mL Rifampicintranscription

-0.422

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.898

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.207

CPZ10-50 ug/mL Chlorpromazinerespiration

1.094

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.130

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.000

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.000

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.263

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.549

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.121

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.207

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.747

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.000

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-0.590

Nigericin50 uM Nigericinrespiration

-0.131

TRC10-150 ug/mL Triclosanrespiration

0.000

TRZ10-25 ug/mL Thioridazinerespiration

4.293

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.938

menadione6-10 ug/mL Menadionerespiration

0.073

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.349

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.276

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.514

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.356

NRP_1Non-replicating persistence stage 1dosRassociated

-0.389

Amp0.2mg/mL AmpicillincellWall

-0.181

Cephalexin20-100 ug/mL CephalexincellWall

-0.060

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.195

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.013

EMB10-20 ug/mL EthambutolcellWall

-0.201

Eta12-40 ug/mL EthionamidecellWall

-0.198

INH0.2-0.4 ug/mL IsoniazidcellWall

0.036

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.000

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.067

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.085

BZA0.12 mg/mL BenzamidearomaticAmides

-0.405

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.176

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.000

H2O24 mM hydrogen peroxideDNAdamaging

-0.292

Levo10 ug/mL LevofloxacinDNAdamaging

-0.462

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.868

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.107

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.719

UVUV-irradiationDNAdamaging

0.000

ARP41-4 ug/mL Antitubercular compound ARP4?

0.069

Antimycin12.5-50 ug/mL Antimycin A?

-0.818

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.329

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.088

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.189

PA8240.2-2 ug/mL PA-824?

0.654

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.398

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.675

Verapamil50 uM Verapamil?

-0.691

mercaptoethanol2 mM 2-Mercaptoethanol?

0.264

methoxatin10-20 ug/mL Methoxatin?